Journal: Journal of Orthopaedic Translation
Article Title: Cyclooxygenase-2 regulates PTHrP transcription in human articular chondrocytes and is involved in the pathophysiology of osteoarthritis in rats
doi: 10.1016/j.jot.2021.06.003
Figure Lengend Snippet: Celecoxib reduces type X collagen, MMP13 and PTHrP levels and inhibits type II collagen expression in osteoarthritic articular cartilage (A) Immunohistochemical analysis of type X collagen (scale bars: 100 μm) (B) MMP13 (scale bars: 200 μm) (C) type II collagen, and (D) PTHrP (scale bars: 100 μm) in articular cartilage of tibia sections in the OA + Saline and OA + Celec groups. The histogram illustrates the quantification of the positively stained type X collagen and the relative density of MMP13, type II collagen and PTHrP expression in articular cartilage. Each column represents the mean ± SEM of six samples. Data from each group were compared with those of the OA contralateral control group and were evaluated by one-way ANOVA and Scheffe's test. ∗, P < 0.05; ∗∗, P < 0.01; the OA + Celec groups compared to the OA + Saline groups # , P < 0.05; ## , P < 0.01.
Article Snippet: Sections were then blocked with 10% FBS for 1 h and incubated with primary antibodies against type II collagen (1:2000; mouse monoclonal antibody; Chemi-Con, Temecula, CA), type X collagen (rat polyclonal antibody) (1:200; Cosmo Bio, Tokyo, Japan), COX-2 (rabbit polyclonal antibody) (1:50; Santa Cruz, Europe), PTHrP (rabbit polyclonal antibody) (1:100; OriGene, MD, USA) and MMP13 (1:200; rabbit polyclonal antibody) (1:100; Bioss, MA, USA) at 4 °C overnight.
Techniques: Expressing, Immunohistochemical staining, Staining